,Open,High,Low,Close,Adjusted Close,Volume,Dividend Amount,Split Coefficient,Symbol,AssetType,Name,Description,CIK,Exchange,Currency,Country,Sector,Industry,Address,OfficialSite,FiscalYearEnd,LatestQuarter,MarketCapitalization,EBITDA,PERatio,PEGRatio,BookValue,DividendPerShare,DividendYield,EPS,RevenuePerShareTTM,ProfitMargin,OperatingMarginTTM,ReturnOnAssetsTTM,ReturnOnEquityTTM,RevenueTTM,GrossProfitTTM,DilutedEPSTTM,QuarterlyEarningsGrowthYOY,QuarterlyRevenueGrowthYOY,AnalystTargetPrice,AnalystRatingStrongBuy,AnalystRatingBuy,AnalystRatingHold,AnalystRatingSell,AnalystRatingStrongSell,TrailingPE,ForwardPE,PriceToSalesRatioTTM,PriceToBookRatio,EVToRevenue,EVToEBITDA,Beta,52WeekHigh,52WeekLow,50DayMovingAverage,200DayMovingAverage,SharesOutstanding,SharesFloat,PercentInsiders,PercentInstitutions,DividendDate,ExDividendDate
2018-12-07,22.000000,22.750000,18.510000,18.600000,18.600000,12995569,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2018-12-10,18.900000,19.439000,18.000000,18.800000,18.800000,4233345,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2018-12-11,20.550000,20.660000,17.990000,18.010000,18.010000,3435271,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2018-12-12,18.550000,19.480000,18.020000,18.680000,18.680000,2590873,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2018-12-13,19.250000,19.290000,18.680000,18.760000,18.760000,1608629,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2018-12-14,18.750000,18.881000,18.250000,18.320000,18.320000,746412,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2018-12-17,18.330000,18.470000,16.900000,17.000000,17.000000,1581242,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2018-12-18,17.100000,17.250000,16.250000,17.000000,17.000000,1621904,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2018-12-19,16.860000,17.370000,16.000000,16.180000,16.180000,941528,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2018-12-20,16.000000,16.140000,14.750000,15.500000,15.500000,2365203,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2018-12-21,15.400000,15.500000,13.950000,14.470000,14.470000,2063235,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2018-12-24,14.320000,14.320000,13.750000,14.030000,14.030000,665427,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2018-12-26,14.150000,14.310000,13.030000,13.520000,13.520000,1817977,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2018-12-27,13.490000,14.950000,13.270000,14.650000,14.650000,1769545,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2018-12-28,14.720000,14.850000,13.818400,14.150000,14.150000,929098,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2018-12-31,14.240000,15.300000,14.212900,15.270000,15.270000,994726,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-01-02,14.930000,15.450000,14.510000,15.330000,15.330000,2318094,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-01-03,15.490000,16.080000,15.200000,15.500000,15.500000,1588921,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-01-04,16.000000,17.500000,15.894000,16.960000,16.960000,1652033,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-01-07,17.540000,17.940000,16.180000,16.270000,16.270000,1585442,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-01-08,17.350000,17.468000,16.050000,16.950000,16.950000,1892977,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-01-09,17.200000,17.250000,16.150000,16.330000,16.330000,1187350,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-01-10,16.360000,16.510000,16.000000,16.480000,16.480000,487284,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-01-11,16.600000,17.060000,16.530000,17.000000,17.000000,580570,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-01-14,17.000000,17.060000,16.720000,16.740000,16.740000,612922,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-01-15,17.000000,17.000000,16.410000,16.590000,16.590000,468080,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-01-16,16.800000,16.950000,16.260000,16.260000,16.260000,272804,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-01-17,16.050000,16.530000,16.050000,16.310000,16.310000,315678,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-01-18,16.460000,16.800000,16.250000,16.690000,16.690000,629965,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-01-22,16.620000,16.634500,15.350000,15.560000,15.560000,637008,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-01-23,15.590000,15.920000,14.760000,14.790000,14.790000,652602,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-01-24,14.900000,15.195000,14.640000,14.640000,14.640000,452909,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-01-25,14.800000,14.920000,14.400000,14.910000,14.910000,942270,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-01-28,14.840000,14.840000,14.450000,14.450000,14.450000,656524,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-01-29,14.460000,14.875000,14.450000,14.630000,14.630000,592755,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-01-30,14.720000,15.545000,14.650000,15.130000,15.130000,758899,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-01-31,15.240000,17.480000,15.240000,16.600000,16.600000,2259191,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-02-01,16.800000,17.008000,15.900000,16.220000,16.220000,617271,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-02-04,16.220000,16.490000,15.950000,16.270000,16.270000,297821,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-02-05,16.290000,17.490000,16.208000,17.180000,17.180000,652724,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-02-06,17.250000,18.390000,17.110000,18.140000,18.140000,1016165,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-02-07,17.950000,18.068000,17.040000,17.050000,17.050000,527579,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-02-08,17.100000,18.150000,17.100000,17.990000,17.990000,685755,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-02-11,17.990000,18.646000,17.751000,18.170000,18.170000,597966,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-02-12,18.210000,18.760000,17.600000,18.690000,18.690000,753128,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-02-13,18.990000,19.220000,18.300000,18.530000,18.530000,1333533,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-02-14,18.640000,19.960000,18.630000,19.660000,19.660000,1091396,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-02-15,19.940000,21.467000,19.700000,21.440000,21.440000,2087409,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-02-19,21.510000,21.513000,20.050000,20.830000,20.830000,1204705,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-02-20,21.120000,21.240000,19.130000,19.920000,19.920000,1160160,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-02-21,19.740000,19.980000,18.880000,19.340000,19.340000,822625,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-02-22,19.350000,20.040000,19.350000,19.880000,19.880000,567612,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-02-25,20.540000,22.300000,19.830000,21.650000,21.650000,1917872,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-02-26,21.600000,24.400000,21.560000,23.700000,23.700000,2522800,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-02-27,23.370000,23.830000,21.530000,22.100000,22.100000,1553011,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-02-28,22.450000,23.030000,22.050000,22.600000,22.600000,511289,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-03-01,23.090000,23.390000,21.640000,22.270000,22.270000,867388,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-03-04,22.470000,22.800000,20.520000,21.120000,21.120000,1134144,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-03-05,21.180000,21.490000,20.290000,21.370000,21.370000,1086443,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-03-06,21.400000,22.050000,20.060000,20.650000,20.650000,1061369,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-03-07,20.420000,21.155000,19.612000,20.590000,20.590000,1018084,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-03-08,20.370000,21.080000,19.900000,20.930000,20.930000,631133,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-03-11,20.990000,20.990000,19.970000,20.430000,20.430000,915642,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-03-12,20.520000,20.890000,19.120000,19.260000,19.260000,1627932,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-03-13,19.300000,20.255000,19.230000,19.970000,19.970000,756588,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-03-14,19.920000,21.000000,19.920000,20.820000,20.820000,883581,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-03-15,20.990000,22.190000,20.890000,21.820000,21.820000,2686871,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-03-18,21.740000,22.220000,21.220000,22.180000,22.180000,1245672,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-03-19,22.470000,22.600000,20.180000,20.350000,20.350000,976101,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-03-20,20.410000,20.980000,19.900000,20.000000,20.000000,985298,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-03-21,20.000000,20.250000,19.210000,19.340000,19.340000,860506,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-03-22,19.380000,19.700000,18.750000,19.000000,19.000000,579495,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-03-25,19.000000,19.590000,18.210000,19.400000,19.400000,671669,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-03-26,19.610000,19.940000,19.240000,19.900000,19.900000,393884,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-03-27,20.080000,20.080000,18.890000,19.270000,19.270000,602641,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-03-28,19.300000,19.740000,19.000000,19.660000,19.660000,453586,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-03-29,19.870000,20.800000,19.470000,20.350000,20.350000,660854,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-04-01,20.540000,20.915000,20.040000,20.590000,20.590000,547566,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-04-02,20.680000,20.680000,19.540000,19.700000,19.700000,546568,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-04-03,19.920000,21.670000,19.810000,21.330000,21.330000,909317,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-04-04,21.120000,23.180000,21.040000,23.080000,23.080000,1705896,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-04-05,23.800000,26.230000,22.665000,25.960000,25.960000,1978459,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-04-08,25.900000,29.790000,25.600000,27.230000,27.230000,2673297,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-04-09,27.300000,28.400000,26.311000,26.820000,26.820000,1051702,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-04-10,26.900000,27.740000,26.500000,26.800000,26.800000,639414,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-04-11,26.820000,26.990000,24.260000,25.730000,25.730000,1030056,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-04-12,26.000000,26.051000,24.270000,24.610000,24.610000,708634,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-04-15,24.990000,25.940000,24.620000,25.840000,25.840000,636494,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-04-16,26.000000,26.220000,23.650000,23.780000,23.780000,964841,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-04-17,24.000000,24.120000,22.314000,23.500000,23.500000,918561,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-04-18,23.470000,23.550000,22.430000,22.510000,22.510000,736355,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-04-22,22.700000,23.990000,22.511000,23.630000,23.630000,494149,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-04-23,23.730000,24.983000,23.730000,24.700000,24.700000,617759,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-04-24,24.800000,25.760000,24.290000,25.760000,25.760000,702199,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-04-25,25.760000,26.720000,25.430000,25.740000,25.740000,603274,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-04-26,25.830000,27.300000,25.690000,26.260000,26.260000,593558,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-04-29,26.280000,27.200000,24.971000,25.140000,25.140000,1057858,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-04-30,25.280000,26.030000,25.000000,26.030000,26.030000,620718,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-05-01,26.310000,27.090000,25.870000,26.400000,26.400000,1121529,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-05-02,26.330000,28.490000,26.190000,28.340000,28.340000,1079697,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-05-03,28.890000,28.950000,26.850000,27.200000,27.200000,837921,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-05-06,26.380000,27.810000,26.250000,27.100000,27.100000,667204,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-05-07,27.180000,27.256000,24.160000,24.550000,24.550000,1061288,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-05-08,23.700000,26.000000,23.530000,23.540000,23.540000,1023854,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-05-09,23.500000,24.000000,22.750000,23.260000,23.260000,523118,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-05-10,23.040000,24.930000,22.800000,24.920000,24.920000,536230,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-05-13,24.460000,24.770000,23.225000,24.430000,24.430000,491784,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-05-14,24.500000,24.890000,23.570000,23.590000,23.590000,473926,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-05-15,23.460000,23.840000,22.810000,23.120000,23.120000,847323,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-05-16,23.500000,24.050000,23.150000,23.460000,23.460000,536569,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-05-17,23.310000,23.429000,21.680000,23.080000,23.080000,1275232,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-05-20,22.850000,23.600000,22.550000,22.600000,22.600000,553004,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-05-21,22.650000,23.160000,22.430000,22.700000,22.700000,475913,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-05-22,22.650000,22.768000,21.930000,22.000000,22.000000,569589,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-05-23,21.750000,21.940000,21.010000,21.380000,21.380000,739551,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-05-24,21.560000,22.000000,21.410000,21.830000,21.830000,743997,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-05-28,22.300000,22.460000,21.440000,21.540000,21.540000,616013,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-05-29,21.710000,21.898000,21.160000,21.700000,21.700000,490742,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-05-30,21.840000,21.900000,21.050000,21.490000,21.490000,361293,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-05-31,21.160000,21.380000,20.740000,20.780000,20.780000,443530,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-06-03,20.790000,20.990000,18.820000,19.850000,19.850000,1031947,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-06-04,19.760000,20.740000,19.230000,19.470000,19.470000,1077687,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-06-05,19.200000,19.200000,17.200000,17.700000,17.700000,5046143,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-06-06,17.830000,18.921000,17.610000,17.940000,17.940000,6066383,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-06-07,17.710000,18.400000,17.300000,17.520000,17.520000,1892799,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-06-10,17.850000,17.990000,15.670000,15.670000,15.670000,2574686,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-06-11,16.090000,16.880000,15.750000,16.000000,16.000000,5614358,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-06-12,16.110000,16.360000,15.620000,16.300000,16.300000,2042477,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-06-13,16.420000,17.590000,16.050000,16.160000,16.160000,1607294,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-06-14,16.250000,16.675000,15.320000,15.400000,15.400000,2080053,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-06-17,15.540000,15.850000,15.280000,15.770000,15.770000,1220436,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-06-18,15.900000,16.190000,15.578000,15.740000,15.740000,1120185,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-06-19,15.750000,16.302500,15.370000,15.500000,15.500000,2831087,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-06-20,15.850000,15.935000,14.860000,15.180000,15.180000,1605381,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-06-21,15.200000,15.320000,14.500000,14.700000,14.700000,2115818,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-06-24,14.410000,14.691000,14.020000,14.040000,14.040000,1327256,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-06-25,14.110000,14.250000,13.650000,13.770000,13.770000,1936251,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-06-26,13.920000,14.180000,13.650000,13.700000,13.700000,1112795,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-06-27,13.500000,14.405000,13.500000,14.340000,14.340000,1724611,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-06-28,14.410000,14.640000,14.110000,14.640000,14.640000,1657027,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-07-01,14.860000,15.080000,14.470000,14.730000,14.730000,1135482,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-07-02,14.710000,14.710000,14.000000,14.400000,14.400000,1202267,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-07-03,14.500000,15.330000,14.400000,15.310000,15.310000,954475,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-07-05,15.470000,15.470000,14.830000,14.960000,14.960000,970638,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-07-08,14.890000,14.900000,14.140000,14.290000,14.290000,938422,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-07-09,14.310000,14.850000,14.150000,14.850000,14.850000,739829,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-07-10,14.940000,15.220000,14.050000,14.480000,14.480000,1770209,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-07-11,14.560000,14.700000,14.120000,14.440000,14.440000,1135170,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-07-12,14.270000,14.480000,14.060000,14.200000,14.200000,1084328,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-07-15,14.280000,14.460000,14.000000,14.320000,14.320000,727620,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-07-16,14.320000,14.475000,14.000000,14.140000,14.140000,1111014,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-07-17,14.170000,14.590000,14.000000,14.030000,14.030000,1202450,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-07-18,14.090000,14.280000,13.900000,14.260000,14.260000,756865,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-07-19,14.290000,14.400000,14.010000,14.110000,14.110000,1042632,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-07-22,14.220000,14.320000,13.910000,14.050000,14.050000,1058910,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-07-23,14.060000,14.130000,13.120000,13.600000,13.600000,2053347,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-07-24,13.750000,14.520000,13.473000,14.470000,14.470000,1167362,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-07-25,14.510000,14.650000,13.500000,13.510000,13.510000,895579,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-07-26,13.590000,14.180000,13.360000,14.120000,14.120000,669060,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-07-29,14.170000,14.330000,13.560000,13.690000,13.690000,1049628,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-07-30,13.610000,13.760000,13.290000,13.400000,13.400000,929543,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-07-31,13.420000,13.510000,13.040000,13.100000,13.100000,1087643,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-08-01,13.200000,13.400000,12.710000,13.010000,13.010000,1502334,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-08-02,13.000000,13.037000,12.400000,12.730000,12.730000,1180381,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-08-05,12.550000,12.690000,12.200000,12.260000,12.260000,1038153,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-08-06,12.500000,12.868000,11.900000,12.290000,12.290000,2007725,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-08-07,12.260000,14.500000,11.540000,12.850000,12.850000,3003267,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-08-08,12.910000,13.300000,12.300000,13.190000,13.190000,1500881,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-08-09,13.140000,13.550000,12.970000,13.330000,13.330000,745194,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-08-12,13.420000,13.680000,12.984000,13.020000,13.020000,780306,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-08-13,13.000000,13.395000,12.760000,13.300000,13.300000,558994,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-08-14,13.080000,13.220000,12.500000,12.740000,12.740000,1362976,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-08-15,12.720000,12.950000,12.470000,12.670000,12.670000,1162846,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-08-16,12.850000,13.240000,12.790000,13.160000,13.160000,1105105,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-08-19,13.250000,13.500000,13.020000,13.400000,13.400000,1955457,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-08-20,13.870000,14.650000,13.600000,14.150000,14.150000,3367012,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-08-21,14.250000,14.410000,13.760000,14.290000,14.290000,1417709,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-08-22,14.370000,14.430000,14.040000,14.160000,14.160000,1023419,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-08-23,14.080000,14.360000,13.830000,13.880000,13.880000,1501049,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-08-26,14.010000,15.380000,14.000000,14.970000,14.970000,3153425,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-08-27,15.170000,15.500000,14.120000,14.510000,14.510000,2720189,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-08-28,14.510000,15.040000,14.380000,14.820000,14.820000,1451650,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-08-29,14.910000,15.200000,14.610000,15.180000,15.180000,1684181,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-08-30,15.300000,15.750000,15.200000,15.730000,15.730000,1601551,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-09-03,16.100000,16.500000,14.350000,14.880000,14.880000,2508895,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-09-04,15.110000,15.590000,14.800000,15.420000,15.420000,1555729,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-09-05,15.650000,16.130000,15.020000,15.530000,15.530000,1394529,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-09-06,15.560000,16.180000,15.140000,15.880000,15.880000,2042503,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-09-09,15.980000,16.230000,15.360000,16.030000,16.030000,2311752,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-09-10,16.060000,17.340000,15.970000,17.090000,17.090000,3077421,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-09-11,17.340000,17.590000,15.890000,15.920000,15.920000,3590692,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-09-12,16.230000,18.460000,16.200000,16.400000,16.400000,8290874,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-09-13,16.450000,17.040000,16.060000,16.710000,16.710000,3162383,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-09-16,16.730000,17.310000,16.690000,17.050000,17.050000,3053899,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-09-17,17.460000,17.950000,17.190000,17.660000,17.660000,5239640,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-09-18,17.770000,18.000000,17.350000,17.780000,17.780000,5834569,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-09-19,17.710000,18.420000,17.617000,17.900000,17.900000,5866926,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-09-20,18.140000,18.390000,17.750000,18.070000,18.070000,25237508,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-09-23,18.240000,18.480000,17.560000,17.830000,17.830000,4861272,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-09-24,17.830000,17.990000,17.250000,17.820000,17.820000,5213302,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-09-25,17.710000,17.710000,17.100000,17.180000,17.180000,3045069,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-09-26,17.410000,17.510000,16.145000,16.340000,16.340000,4449091,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-09-27,16.290000,16.540000,15.675000,15.900000,15.900000,2309047,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-09-30,15.790000,16.270000,15.670000,15.920000,15.920000,1532173,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-10-01,15.870000,16.060000,14.800000,14.810000,14.810000,1544925,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-10-02,14.780000,15.010000,14.420000,14.860000,14.860000,1783307,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-10-03,15.240000,15.240000,14.410000,15.070000,15.070000,1464168,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-10-04,15.050000,15.570000,14.890000,15.510000,15.510000,1022019,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-10-07,15.450000,15.630000,15.070000,15.470000,15.470000,1373936,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-10-08,15.360000,15.480000,15.010000,15.310000,15.310000,1226190,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-10-09,15.330000,15.550000,14.180000,14.200000,14.200000,2386365,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-10-10,14.130000,14.410000,13.870000,14.160000,14.160000,1345771,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-10-11,14.240000,14.700000,13.990000,14.055000,14.055000,941288,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-10-14,14.190000,14.270000,13.670000,13.930000,13.930000,960535,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-10-15,13.930000,14.450000,13.530000,14.330000,14.330000,1157446,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-10-16,14.270000,14.320000,14.020000,14.150000,14.150000,915084,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-10-17,14.230000,14.720000,14.150000,14.540000,14.540000,1033914,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-10-18,14.500000,14.850000,14.070000,14.810000,14.810000,1596419,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-10-21,14.900000,15.590000,14.660000,15.500000,15.500000,930868,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-10-22,15.560000,16.090000,15.550000,15.920000,15.920000,594156,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-10-23,16.160000,17.010000,16.090000,16.900000,16.900000,1512239,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-10-24,16.920000,17.030000,16.050000,16.590000,16.590000,1112146,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-10-25,16.730000,17.100000,16.430000,17.010000,17.010000,737109,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-10-28,17.010000,17.150000,16.809000,17.030000,17.030000,652386,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-10-29,16.960000,17.155000,16.660000,16.990000,16.990000,751727,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-10-30,16.950000,17.240000,16.520000,17.140000,17.140000,961150,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-10-31,17.030000,17.150000,16.490000,16.750000,16.750000,1015552,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-11-01,16.800000,16.894000,15.520000,15.660000,15.660000,1603732,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-11-04,15.900000,16.800000,15.830000,16.800000,16.800000,1357932,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-11-05,16.940000,17.720000,16.710000,16.890000,16.890000,1742360,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-11-06,16.830000,17.490000,16.050000,16.130000,16.130000,1575549,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-11-07,16.330000,17.608000,16.280000,17.500000,17.500000,2043611,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-11-08,17.250000,17.500000,17.110000,17.490000,17.490000,973669,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-11-11,17.330000,17.520000,17.200000,17.400000,17.400000,949933,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-11-12,17.340000,18.100000,17.303000,17.990000,17.990000,1978343,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-11-13,18.000000,18.500000,17.710000,18.250000,18.250000,2014902,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-11-14,18.160000,18.500000,17.910000,18.340000,18.340000,1532586,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-11-15,18.390000,19.430000,18.350000,19.370000,19.370000,1882089,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-11-18,19.210000,19.450000,18.670000,19.450000,19.450000,923140,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-11-19,19.270000,19.870000,19.082000,19.360000,19.360000,1144750,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-11-20,19.380000,20.400000,19.350000,20.180000,20.180000,2316542,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-11-21,19.980000,20.320000,19.690000,20.200000,20.200000,1202497,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-11-22,20.070000,20.730000,19.860000,20.690000,20.690000,1443557,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-11-25,20.900000,21.000000,19.950000,20.000000,20.000000,1927782,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-11-26,20.037000,20.650000,19.820000,20.330000,20.330000,1549446,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-11-27,20.280000,20.700000,19.990000,20.370000,20.370000,1561222,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-11-29,20.600000,20.930000,20.280000,20.360000,20.360000,1186734,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-12-02,20.300000,20.540000,19.600000,19.760000,19.760000,1186785,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-12-03,19.480000,21.370000,19.410000,21.280000,21.280000,1795347,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-12-04,21.000000,21.470000,20.933000,21.270000,21.270000,1980055,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-12-05,21.490000,21.500000,20.570000,20.640000,20.640000,1478421,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-12-06,20.780000,21.040000,18.820000,18.940000,18.940000,3537657,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-12-09,19.070000,19.300000,18.670000,18.780000,18.780000,2823956,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-12-10,18.780000,19.090000,18.580000,18.870000,18.870000,1619895,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-12-11,19.030000,19.110000,18.530000,18.650000,18.650000,1233120,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-12-12,18.560000,19.045000,18.320000,18.450000,18.450000,1313402,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-12-13,18.470000,18.720000,18.320000,18.620000,18.620000,1302439,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-12-16,18.600000,18.970000,18.220000,18.520000,18.520000,1785541,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-12-17,18.540000,18.700000,18.310000,18.440000,18.440000,1647786,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-12-18,18.480000,19.000000,18.480000,18.640000,18.640000,1277655,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-12-19,18.580000,19.670000,18.500000,19.410000,19.410000,2101681,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-12-20,19.400000,20.000000,19.050000,19.830000,19.830000,10931559,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-12-23,19.790000,19.850000,19.340000,19.700000,19.700000,1789840,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-12-24,19.690000,19.790000,19.350000,19.750000,19.750000,488921,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-12-26,19.820000,20.110000,19.660000,19.860000,19.860000,750317,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-12-27,19.990000,20.000000,19.250000,19.520000,19.520000,1046852,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-12-30,19.540000,19.940000,18.940000,19.050000,19.050000,1183298,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2019-12-31,18.960000,19.640000,18.960000,19.560000,19.560000,1112406,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-01-02,19.570000,19.810000,18.880000,19.230000,19.230000,1229434,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-01-03,19.020000,19.360000,18.720000,18.890000,18.890000,1750976,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-01-06,18.700000,18.740000,18.010000,18.130000,18.130000,1606505,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-01-07,18.150000,18.320000,17.680000,17.780000,17.780000,1461935,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-01-08,17.990000,18.080000,17.760000,17.980000,17.980000,1041551,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-01-09,18.000000,18.550000,17.900000,18.400000,18.400000,1531344,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-01-10,21.000000,21.000000,19.050000,19.140000,19.140000,4504819,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-01-13,19.260000,20.360000,18.600000,20.260000,20.260000,2190126,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-01-14,20.450000,20.498000,19.550000,20.000000,20.000000,1782859,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-01-15,19.940000,20.580000,19.940000,20.240000,20.240000,2054963,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-01-16,21.680000,21.870000,20.770000,21.010000,21.010000,4928102,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-01-17,21.500000,21.500000,20.550000,20.620000,20.620000,3348525,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-01-21,20.790000,21.490000,20.645000,20.940000,20.940000,2088535,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-01-22,22.080000,23.200000,21.700000,21.970000,21.970000,10920657,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-01-23,22.170000,22.650000,21.400000,21.470000,21.470000,3663943,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-01-24,21.600000,21.879000,20.900000,21.120000,21.120000,2947764,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-01-27,22.100000,23.120000,21.120000,22.740000,22.740000,10294739,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-01-28,23.500000,23.500000,21.850000,22.360000,22.360000,5649269,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-01-29,22.230000,22.340000,20.450000,20.550000,20.550000,4675832,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-01-30,21.050000,21.740000,20.800000,20.990000,20.990000,3061810,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-01-31,21.140000,21.320000,20.050000,20.510000,20.510000,2833631,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-02-03,20.660000,21.060000,19.700000,20.380000,20.380000,3214618,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-02-04,20.090000,20.880000,19.750000,20.870000,20.870000,1824436,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-02-05,20.990000,21.200000,19.670000,20.050000,20.050000,2656824,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-02-06,20.270000,20.320000,19.700000,19.880000,19.880000,1929739,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-02-07,19.790000,23.390000,19.790000,23.240000,23.240000,10144169,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-02-10,23.500000,23.950000,22.383000,23.650000,23.650000,9356771,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-02-11,22.090000,22.740000,21.280000,21.350000,21.350000,6188339,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-02-12,19.640000,19.670000,18.500000,19.010000,19.010000,19231794,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-02-13,19.360000,19.800000,18.890000,19.045000,19.045000,6837002,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-02-14,19.270000,19.290000,18.850000,19.000000,19.000000,5384464,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-02-18,19.140000,19.350000,18.570000,18.910000,18.910000,4129369,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-02-19,19.090000,19.240000,18.725000,18.920000,18.920000,3148012,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-02-20,18.860000,19.170000,18.420000,18.540000,18.540000,4562216,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-02-21,18.470000,18.550000,17.910000,18.230000,18.230000,3696712,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-02-24,19.230000,19.280000,18.300000,18.590000,18.590000,7605391,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-02-25,22.150000,26.550000,20.510000,23.760000,23.760000,65001881,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-02-26,29.050000,29.980000,27.080000,29.160000,29.160000,78016785,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-02-27,35.880000,36.000000,23.050000,26.160000,26.160000,68256337,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-02-28,23.380000,25.950000,22.015000,25.930000,25.930000,24425125,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-03-02,27.000000,30.750000,25.210000,29.880000,29.880000,33084026,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-03-03,27.804000,28.600000,26.600000,27.910000,27.910000,17599114,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-03-04,27.990000,28.720000,26.800000,27.490000,27.490000,11817666,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-03-05,27.490000,28.950000,26.535000,28.010000,28.010000,14669976,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-03-06,27.980000,29.800000,27.670000,29.610000,29.610000,21097488,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-03-09,30.000000,30.000000,24.160000,24.290000,24.290000,14124076,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-03-10,25.710000,25.940000,21.280000,22.340000,22.340000,13019516,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-03-11,22.540000,25.749000,22.524000,23.610000,23.610000,14825434,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-03-12,22.900000,24.280000,21.900000,22.300000,22.300000,11305347,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-03-13,23.000000,23.470000,19.310000,21.300000,21.300000,11853052,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-03-16,23.760000,27.800000,22.220000,26.490000,26.490000,39850785,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-03-17,29.360000,32.700000,27.315000,28.180000,28.180000,44484144,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-03-18,27.130000,32.540000,26.550000,31.580000,31.580000,28655958,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-03-19,32.780000,34.980000,25.190000,28.270000,28.270000,36952753,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-03-20,29.250000,30.230000,26.200000,28.200000,28.200000,16522449,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-03-23,28.710000,29.810000,26.250000,26.570000,26.570000,11080845,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-03-24,27.090000,27.250000,24.360000,25.820000,25.820000,12550494,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-03-25,25.000000,27.980000,24.790000,27.130000,27.130000,9651543,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-03-26,27.560000,28.790000,27.560000,27.940000,27.940000,5585886,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-03-27,28.370000,31.090000,27.950000,30.050000,30.050000,12408297,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-03-30,30.590000,31.690000,28.270000,30.480000,30.480000,10749923,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-03-31,30.600000,30.980000,29.200000,29.950000,29.950000,6027880,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-04-01,30.050000,30.940000,29.440000,29.670000,29.670000,7004587,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-04-02,30.600000,33.390000,29.840000,33.200000,33.200000,15934404,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-04-03,32.810000,35.660000,32.720000,34.840000,34.840000,16896224,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-04-06,34.910000,35.185000,33.330000,34.640000,34.640000,10841594,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-04-07,33.810000,34.030000,30.980000,32.020000,32.020000,10104337,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-04-08,32.360000,32.940000,31.750000,32.420000,32.420000,4119844,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-04-09,32.550000,32.920000,31.320000,31.860000,31.860000,4861753,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-04-13,32.000000,32.980000,31.710000,32.900000,32.900000,5603883,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-04-14,34.000000,34.990000,33.150000,34.660000,34.660000,8126897,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-04-15,34.640000,38.450000,33.720000,37.250000,37.250000,15682994,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-04-16,38.074000,41.550000,36.620000,40.600000,40.600000,20670718,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-04-17,48.990000,49.000000,43.380000,46.850000,46.850000,32285976,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-04-20,45.000000,54.950000,44.510000,51.690000,51.690000,34102467,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-04-21,53.000000,56.380000,43.110000,49.260000,49.260000,39641959,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-04-22,50.610000,51.820000,49.060000,51.200000,51.200000,11690439,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-04-23,49.100000,50.700000,46.890000,47.440000,47.440000,15152351,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-04-24,47.150000,50.500000,47.142000,50.500000,50.500000,11712457,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-04-27,51.530000,51.700000,47.300000,48.050000,48.050000,13744397,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-04-28,50.400000,50.450000,47.170000,47.880000,47.880000,13067207,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-04-29,46.600000,46.950000,45.010000,46.370000,46.370000,11761966,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-04-30,46.780000,48.370000,45.820000,45.990000,45.990000,7741871,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-05-01,48.710000,50.450000,46.290000,47.930000,47.930000,21701291,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-05-04,48.050000,50.500000,48.000000,50.500000,50.500000,10460549,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-05-05,50.480000,50.960000,47.230000,49.340000,49.340000,11160180,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-05-06,48.450000,49.250000,47.520000,48.950000,48.950000,6692345,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-05-07,55.780000,55.990000,51.060000,53.190000,53.190000,30942700,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-05-08,53.060000,59.880000,52.150000,59.250000,59.250000,24135545,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-05-11,59.600000,67.670000,59.140000,66.900000,66.900000,34852044,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-05-12,65.990000,68.490000,62.020000,62.350000,62.350000,25934464,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-05-13,63.800000,66.970000,60.290000,65.180000,65.180000,22125959,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-05-14,64.790000,65.390000,61.440000,64.560000,64.560000,12198249,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-05-15,63.790000,67.670000,63.010000,66.690000,66.690000,16341869,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-05-18,86.140000,87.000000,75.660000,80.000000,80.000000,81209374,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-05-19,78.070000,79.750000,70.320000,71.670000,71.670000,64932254,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-05-20,70.010000,74.480000,67.410000,73.470000,73.470000,53655278,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-05-21,73.050000,73.160000,65.310000,67.050000,67.050000,35195611,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-05-22,69.930000,70.600000,67.140000,69.000000,69.000000,28912678,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-05-26,66.400000,66.590000,57.050000,57.710000,57.710000,40332555,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-05-27,51.200000,53.340000,46.130000,52.180000,52.180000,59514749,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-05-28,53.500000,59.110000,53.350000,55.540000,55.540000,32308594,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-05-29,57.450000,61.650000,56.560000,61.500000,61.500000,38224872,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-06-01,62.760000,63.900000,60.510000,62.180000,62.180000,21257477,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-06-02,58.700000,59.950000,55.355000,59.870000,59.870000,21701140,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-06-03,57.510000,63.370000,57.100000,59.890000,59.890000,20811530,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-06-04,61.610000,61.930000,58.520000,60.590000,60.590000,13503951,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-06-05,58.490000,59.190000,56.630000,58.190000,58.190000,14677935,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-06-08,58.300000,59.380000,56.720000,59.100000,59.100000,11249314,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-06-09,58.550000,59.405000,57.730000,58.230000,58.230000,7600166,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-06-10,58.800000,60.720000,58.600000,60.070000,60.070000,11074361,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-06-11,62.950000,66.687000,58.770000,60.200000,60.200000,32085168,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-06-12,62.355000,63.630000,60.290000,62.000000,62.000000,14742913,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-06-15,65.900000,66.980000,63.424000,66.570000,66.570000,19339289,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-06-16,66.310000,66.600000,62.600000,64.340000,64.340000,16537847,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-06-17,63.600000,65.880000,62.580000,63.310000,63.310000,13615975,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-06-18,63.030000,65.400000,62.580000,64.950000,64.950000,10914379,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-06-19,64.990000,66.450000,64.010000,66.350000,66.350000,16076734,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-06-22,65.920000,66.290000,62.120000,64.750000,64.750000,13586383,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-06-23,64.100000,65.080000,62.740000,62.940000,62.940000,12361339,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-06-24,63.230000,66.156000,63.140000,64.840000,64.840000,14377115,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-06-25,67.000000,67.000000,58.510000,62.000000,62.000000,26905664,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-06-26,60.710000,62.290000,59.140000,61.280000,61.280000,13866283,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-06-29,61.820000,63.000000,59.400000,62.080000,62.080000,8074205,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-06-30,62.180000,65.159000,61.800000,64.210000,64.210000,11955169,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-07-01,63.000000,63.730000,59.120000,61.590000,61.590000,17916470,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-07-02,60.000000,61.800000,55.810000,58.570000,58.570000,26544378,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-07-06,58.550000,60.730000,57.100000,59.150000,59.150000,9977416,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-07-07,58.800000,61.500000,57.440000,61.090000,61.090000,8905273,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-07-08,60.790000,62.460000,59.450000,61.580000,61.580000,7592561,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-07-09,62.090000,65.350000,58.880000,64.960000,64.960000,20688642,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-07-10,64.650000,64.930000,62.320000,62.610000,62.610000,7407645,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-07-13,63.890000,77.750000,63.800000,71.780000,71.780000,56617328,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-07-14,74.000000,76.949000,70.620000,75.040000,75.040000,38709428,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-07-15,87.520000,88.370000,78.010000,80.220000,80.220000,90772455,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-07-16,80.160000,84.290000,79.600000,81.810000,81.810000,27278552,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-07-17,83.350000,95.210000,82.610000,94.850000,94.850000,103508505,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-07-20,87.860000,90.850000,78.050000,82.680000,82.680000,77855098,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-07-21,80.910000,82.430000,79.070000,80.860000,80.860000,26019248,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-07-22,79.610000,84.120000,79.110000,83.225000,83.225000,27274018,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-07-23,82.050000,82.680000,72.200000,75.330000,75.330000,29288088,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-07-24,69.050000,73.900000,66.540000,73.210000,73.210000,27797477,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-07-27,80.630000,80.980000,76.160000,79.910000,79.910000,44710713,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-07-28,81.000000,83.850000,79.500000,81.490000,81.490000,32946885,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-07-29,81.980000,82.820000,76.550200,79.510000,79.510000,24453924,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-07-30,78.000000,79.250000,76.800000,77.630000,77.630000,13101985,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-07-31,78.200000,78.440000,73.603800,74.100000,74.100000,14223411,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-08-03,74.980000,77.990000,73.030000,77.980000,77.980000,13382327,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-08-04,78.192000,78.620000,75.500000,78.460000,78.460000,10126500,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-08-05,77.490000,77.490000,73.690000,75.800000,75.800000,19859902,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-08-06,75.790000,76.250000,73.120000,73.760000,73.760000,11691503,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-08-07,74.380000,75.390000,73.010000,74.100000,74.100000,8771437,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-08-10,74.270000,75.000000,71.410000,72.010000,72.010000,8678274,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-08-11,69.520000,71.400000,67.000000,68.970000,68.970000,18118727,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-08-12,75.670000,75.750000,68.300000,69.520000,69.520000,50471491,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-08-13,69.090000,69.180000,67.050000,67.830000,67.830000,15055934,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-08-14,68.060000,70.360000,67.860000,69.150000,69.150000,12799582,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-08-17,69.140000,70.780000,68.380000,69.760000,69.760000,8703196,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-08-18,68.280000,69.700000,65.230000,67.030000,67.030000,11329150,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-08-19,66.740000,69.170000,66.600000,68.000000,68.000000,8558809,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-08-20,67.790000,68.000000,66.630000,67.810000,67.810000,6346700,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-08-21,67.500000,68.020000,65.600000,66.450000,66.450000,6935608,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-08-24,67.150000,67.850000,62.880000,64.880000,64.880000,13143244,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-08-25,64.320000,66.696000,63.550000,66.250000,66.250000,7798501,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-08-26,67.620000,71.640000,66.030000,70.500000,70.500000,28768082,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-08-27,69.980000,70.320000,67.010000,68.030000,68.030000,9262562,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-08-28,68.040000,68.950000,67.150000,67.490000,67.490000,6383705,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-08-31,67.140000,67.200000,62.540000,64.890000,64.890000,15271802,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-09-01,63.540000,64.500000,62.500000,63.320000,63.320000,8200671,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-09-02,62.840000,64.890000,61.380500,64.720000,64.720000,9874614,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-09-03,65.650000,69.350000,64.300000,64.840000,64.840000,14307317,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-09-04,64.990000,65.000000,59.010000,62.600000,62.600000,11653287,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-09-08,57.750000,58.600000,54.210000,54.340000,54.340000,17706208,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-09-09,56.030000,57.190000,54.510000,56.900000,56.900000,9355441,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-09-10,57.040800,60.320000,56.870000,57.560000,57.560000,7985321,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-09-11,58.490000,59.510000,57.450000,59.340000,59.340000,4821869,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-09-14,60.150000,63.850000,60.115000,63.670000,63.670000,8930779,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-09-15,65.027400,68.410000,64.229300,66.880000,66.880000,9101184,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-09-16,67.640000,70.040000,66.730000,68.840000,68.840000,11398006,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-09-17,68.500000,70.900000,64.600000,67.890000,67.890000,13275199,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-09-18,68.280000,70.000000,66.100000,69.870000,69.870000,13206193,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-09-21,68.600000,69.480000,65.460000,69.260000,69.260000,8223034,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-09-22,67.500000,69.190000,66.670000,68.720000,68.720000,6303612,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-09-23,67.865000,68.620000,65.770000,67.160000,67.160000,6919352,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-09-24,65.500000,66.770000,63.640000,65.170000,65.170000,5565191,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-09-25,65.886500,69.730000,65.670000,69.470000,69.470000,9190629,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-09-28,69.590000,71.500000,69.100000,70.550000,70.550000,7337397,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-09-29,70.460000,71.340000,69.585100,70.520000,70.520000,6294318,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-09-30,72.510000,75.390000,70.160000,70.750000,70.750000,15690706,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-10-01,69.570000,70.200000,68.160000,70.030000,70.030000,6838969,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-10-02,67.900000,72.770000,67.250000,68.810000,68.810000,8004919,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-10-05,69.640000,72.020000,69.050000,71.950000,71.950000,6518121,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-10-06,72.000000,73.920000,70.310000,71.040000,71.040000,7285512,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-10-07,71.230000,73.240000,70.959000,72.370000,72.370000,4190611,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-10-08,73.500000,73.760000,72.010000,72.930000,72.930000,4023816,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-10-09,73.420000,73.670000,72.390000,73.000000,73.000000,4774015,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-10-12,73.610000,75.851400,72.920000,75.310000,75.310000,7590764,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-10-13,75.930000,81.370000,75.520000,78.290000,78.290000,13669187,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-10-14,80.010000,80.010000,76.325200,76.560000,76.560000,6643833,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-10-15,75.480000,76.490000,73.710100,75.580000,75.580000,5014595,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-10-16,76.060000,76.930000,73.665000,73.940000,73.940000,4693584,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-10-19,73.970000,74.090000,70.500000,70.960000,70.960000,6931283,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-10-20,72.070000,73.100000,70.650000,71.310000,71.310000,5441299,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-10-21,71.570000,71.578400,68.060000,68.370000,68.370000,4614813,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-10-22,68.503500,72.530000,68.400000,70.840000,70.840000,5212065,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-10-23,72.300000,72.399700,68.800000,70.530000,70.530000,3735087,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-10-26,70.360000,71.320000,68.700000,70.240000,70.240000,3872799,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-10-27,70.450000,71.350000,68.810000,70.670000,70.670000,3812879,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-10-28,68.950000,69.470000,65.489900,65.740000,65.740000,6043991,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-10-29,68.350000,74.539000,66.230000,71.280000,71.280000,13776433,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-10-30,70.800000,71.490000,66.850000,67.470000,67.470000,7085797,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-11-02,68.020000,68.600000,66.550000,67.110000,67.110000,4650268,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-11-03,66.750000,69.250000,66.590000,69.080000,69.080000,4366928,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-11-04,68.970000,71.550000,68.918800,69.810000,69.810000,5442067,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-11-05,71.090000,71.590000,70.160000,71.480000,71.480000,4449850,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-11-06,71.420000,74.160000,70.870000,72.450000,72.450000,5841047,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-11-09,77.750000,80.250000,75.420000,77.740000,77.740000,20266813,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-11-10,80.000000,80.380000,73.520000,76.050000,76.050000,10499395,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-11-11,77.050000,83.980000,76.130000,82.440000,82.440000,18576496,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-11-12,85.180000,87.930000,83.830000,87.810000,87.810000,21750394,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-11-13,86.620000,90.530000,85.220000,89.390000,89.390000,14176721,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-11-16,100.310000,103.200000,93.300000,97.950000,97.950000,70853055,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-11-17,97.230000,97.800000,91.600000,93.150000,93.150000,26171963,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-11-18,93.870000,94.000000,88.610300,88.890000,88.890000,21823450,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-11-19,90.000000,94.650000,89.511400,92.770000,92.770000,16002015,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-11-20,95.000000,98.430000,94.820000,97.610000,97.610000,15306303,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-11-23,100.770000,101.770000,98.620000,101.030000,101.030000,16359624,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-11-24,98.400000,99.890000,93.540000,98.560000,98.560000,12419962,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-11-25,99.030000,109.290000,98.650000,109.180000,109.180000,25850691,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-11-27,115.120000,130.060000,114.860000,127.030000,127.030000,43438495,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-11-30,144.000000,153.869900,141.050000,152.740000,152.740000,73203064,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-12-01,177.660000,178.500000,130.330000,141.010000,141.010000,124159727,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-12-02,138.630000,149.799900,128.100000,143.000000,143.000000,51217334,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-12-03,143.500000,159.110000,143.010100,157.260000,157.260000,38656507,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-12-04,157.590000,157.820000,148.510000,152.520000,152.520000,27704832,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-12-07,155.030000,163.980000,152.970000,159.520000,159.520000,31409838,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-12-08,165.750000,170.510000,164.300000,169.860000,169.860000,27738717,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-12-09,170.200000,170.800000,147.200000,156.590000,156.590000,40951695,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-12-10,151.130000,159.500000,148.010100,155.690000,155.690000,22059969,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-12-11,159.700000,163.750000,155.890000,156.930000,156.930000,22069857,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-12-14,163.400000,163.761100,152.560600,155.070000,155.070000,22467742,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-12-15,157.000000,157.280000,142.460000,147.220000,147.220000,36451258,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-12-16,137.750000,141.334000,134.310000,137.030000,137.030000,28476275,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-12-17,137.920000,146.970000,137.300000,144.000000,144.000000,32404457,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-12-18,141.510000,145.000000,135.060000,140.230000,140.230000,33157833,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-12-21,140.840000,147.260000,137.790000,138.300000,138.300000,23921047,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-12-22,139.000000,141.400000,123.000000,125.880000,125.880000,36126942,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-12-23,120.050000,132.000000,115.000000,130.340000,130.340000,41905043,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-12-24,125.940000,129.700000,122.720100,123.390000,123.390000,12720588,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-12-28,120.040000,122.880000,111.050000,111.400000,111.400000,30712362,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-12-29,107.795700,116.250000,106.880000,114.390000,114.390000,23718799,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-12-30,118.400000,118.940800,108.800000,111.130000,111.130000,23965535,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2020-12-31,110.550000,113.550000,102.660000,104.470000,104.470000,23369872,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-01-04,107.230000,113.630000,103.260000,111.730000,111.730000,22439554,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-01-05,113.820000,114.980000,107.200000,109.180000,109.180000,15450804,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-01-06,111.110000,116.930000,110.280000,116.260000,116.260000,21590934,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-01-07,120.100000,122.820000,112.130000,115.090000,115.090000,20614071,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-01-08,116.520000,117.710000,111.490000,112.750000,112.750000,12376939,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-01-11,112.750000,121.240000,112.620000,117.260000,117.260000,16650648,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-01-12,117.930000,124.910000,117.120000,124.550000,124.550000,15172207,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-01-13,123.700000,127.580000,120.740000,124.060000,124.060000,14324644,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-01-14,122.800000,130.980000,122.800000,129.720000,129.720000,13346728,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-01-15,129.600000,133.290000,126.580000,129.650000,129.650000,15769535,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-01-19,122.100000,126.360000,120.500000,125.010000,125.010000,16528897,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-01-20,124.510000,126.010100,122.250000,125.140000,125.140000,8001568,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-01-21,125.280000,137.000000,125.250000,132.980000,132.980000,20880838,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-01-22,132.500000,135.870000,128.900000,131.020000,131.020000,10067191,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-01-25,138.400000,147.429900,137.250000,147.000000,147.000000,26970870,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-01-26,145.150000,154.550000,145.000000,151.930000,151.930000,16964726,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-01-27,151.200000,164.550000,149.000000,155.730000,155.730000,20262915,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-01-28,154.105000,168.000000,153.620000,159.550000,159.550000,16497369,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-01-29,174.990000,185.980000,166.200100,173.160000,173.160000,39687298,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-02-01,173.030000,174.500000,154.300000,157.480000,157.480000,22056533,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-02-02,158.520000,159.054000,147.100000,158.580000,158.580000,14861552,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-02-03,156.600000,168.390000,156.400000,165.860000,165.860000,11355915,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-02-04,166.420000,173.730000,164.250000,173.310000,173.310000,10618280,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-02-05,170.990000,177.500000,170.260000,176.240000,176.240000,8990045,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-02-08,177.000000,189.260000,176.810000,185.980000,185.980000,12940157,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-02-09,186.210000,187.000000,177.270000,179.520000,179.520000,8359886,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-02-10,182.740000,185.220000,176.370000,179.340000,179.340000,7018342,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-02-11,178.290000,184.220000,176.200000,183.440000,183.440000,5464092,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-02-12,184.890000,185.000000,177.580000,183.740000,183.740000,5705535,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-02-16,182.410000,184.180000,173.508800,178.530000,178.530000,6917541,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-02-17,174.280000,178.010000,171.620000,176.760000,176.760000,6541124,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-02-18,171.592900,175.470000,168.000000,169.570000,169.570000,5124102,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-02-19,173.540000,179.300000,170.530000,174.740000,174.740000,6413592,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-02-22,167.800000,170.350000,158.580000,159.370000,159.370000,11066579,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-02-23,151.250000,153.000000,136.000000,150.170000,150.170000,15509168,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-02-24,150.410000,151.000000,143.470000,144.790000,144.790000,9757204,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-02-25,150.780000,160.980000,145.860000,148.380000,148.380000,15081025,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-02-26,157.980000,159.600000,150.880000,154.810000,154.810000,13355198,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-03-01,154.463100,157.779900,145.250100,157.400000,157.400000,15351555,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-03-02,153.500000,154.471300,146.440000,146.810000,146.810000,8630604,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-03-03,146.090000,147.320000,131.000000,131.220000,131.220000,13683455,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-03-04,128.700000,135.470000,126.690000,132.300000,132.300000,10929537,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-03-05,133.073200,134.270000,121.120000,132.190000,132.190000,12039641,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-03-08,129.150000,133.550000,122.480000,123.470000,123.470000,6839340,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-03-09,127.110000,132.300000,125.600000,130.870000,130.870000,7834221,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-03-10,133.620000,135.715000,128.793200,129.750000,129.750000,5555909,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-03-11,132.981800,140.850000,131.480000,140.470000,140.470000,8140123,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-03-12,134.040000,138.742400,133.200000,136.990000,136.990000,4923074,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-03-15,136.770000,143.850000,135.010000,143.660000,143.660000,7361627,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-03-16,148.500000,157.750000,145.840000,156.020000,156.020000,16991621,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-03-17,150.250000,152.083100,143.250100,147.550000,147.550000,12894891,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-03-18,144.450000,147.610000,140.860000,141.460000,141.460000,7144867,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-03-19,143.060000,145.180000,138.530000,143.740000,143.740000,6933748,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-03-22,144.190000,147.919900,141.850000,145.600000,145.600000,6050730,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-03-23,145.610000,146.190000,136.380000,136.520000,136.520000,6961240,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-03-24,137.250000,137.740000,131.010000,131.610000,131.610000,5864615,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-03-25,127.330000,134.310000,126.420000,133.330000,133.330000,5696322,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-03-26,133.380000,135.600000,128.020000,133.280000,133.280000,4047117,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-03-29,130.110000,131.300000,121.900000,123.420000,123.420000,10814820,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-03-30,123.150000,123.597700,117.341100,118.490000,118.490000,11061638,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-03-31,121.100000,131.800000,119.328000,130.950000,130.950000,10015691,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-04-01,132.200000,136.637200,130.340000,132.550000,132.550000,7269665,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-04-05,132.600000,133.192500,127.040000,129.910000,129.910000,5218269,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-04-06,130.110000,138.249400,128.160000,133.530000,133.530000,7438195,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-04-07,132.370000,135.160000,130.210000,131.470000,131.470000,4380038,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-04-08,132.850000,135.900000,132.060000,133.880000,133.880000,4530017,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-04-09,133.510000,144.000000,133.340000,140.920000,140.920000,9918176,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-04-12,142.370000,143.490000,136.360000,139.400000,139.400000,6060181,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-04-13,146.800000,152.110000,145.350000,149.710000,149.710000,13729029,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-04-14,153.660000,160.920000,152.490000,160.030000,160.030000,15389838,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-04-15,159.000000,163.580000,155.230000,159.870000,159.870000,10340444,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-04-16,158.680000,171.920000,158.210000,170.810000,170.810000,19044899,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-04-19,166.610000,168.195800,159.600000,161.910000,161.910000,10006646,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-04-20,160.320000,162.730000,153.270000,156.780000,156.780000,7154386,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-04-21,158.600000,170.110000,157.690100,169.500000,169.500000,11352741,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-04-22,168.260000,179.000000,164.620000,168.100000,168.100000,15922383,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-04-23,170.304600,175.510000,168.350000,173.630000,173.630000,8855331,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-04-26,171.790000,179.600000,168.880000,177.610000,177.610000,12201731,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-04-27,178.360400,185.529900,178.180000,183.410000,183.410000,12925677,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-04-28,182.370000,182.890000,176.120000,178.680000,178.680000,8375405,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-04-29,183.326500,186.800000,174.760000,175.670000,175.670000,8362706,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-04-30,175.590000,184.000000,174.520000,178.820000,178.820000,9495237,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-05-03,183.900000,189.000000,182.210100,186.020000,186.020000,14631036,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-05-04,185.334700,188.490000,171.630000,173.590000,173.590000,16924196,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-05-05,178.100000,180.700000,156.810000,162.840000,162.840000,18914247,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-05-06,148.000000,163.470000,143.560000,160.500000,160.500000,29662344,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-05-07,165.780000,169.019600,160.816100,163.150000,163.150000,11952612,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-05-10,164.010000,164.759900,155.710000,158.550000,158.550000,8809685,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-05-11,151.310000,161.990000,150.060000,158.990000,158.990000,8087399,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-05-12,154.110000,158.910000,151.150000,152.680000,152.680000,5720784,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-05-13,152.600000,155.620000,146.850000,149.870000,149.870000,5765024,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-05-14,150.850000,162.460000,150.400000,161.380000,161.380000,6512867,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-05-17,159.000000,163.370000,156.723500,160.430000,160.430000,4231645,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-05-18,160.160000,165.750000,157.900000,159.530000,159.530000,4811395,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-05-19,155.740000,160.070000,154.510000,157.990000,157.990000,3943745,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-05-20,159.920000,166.810000,158.890000,165.970000,165.970000,4826341,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-05-21,168.930000,169.280000,161.350000,161.450000,161.450000,5169131,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-05-24,162.881300,166.800000,161.010000,164.170000,164.170000,4501276,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-05-25,166.560000,171.740000,165.100100,169.260000,169.260000,7759917,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-05-26,168.700000,175.620000,168.510000,175.590000,175.590000,6885242,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-05-27,174.200000,180.000000,173.630000,179.540000,179.540000,10844891,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-05-28,178.623300,186.640000,178.360000,185.010000,185.010000,8567185,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-06-01,184.080000,185.279100,178.800000,184.660000,184.660000,6010881,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-06-02,183.900000,194.500000,183.280000,191.600000,191.600000,10142521,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-06-03,188.890000,200.000000,188.633100,195.220000,195.220000,9270151,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-06-04,197.900000,207.380000,197.330000,206.070000,206.070000,11103272,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-06-07,207.102600,227.710000,206.420000,219.570000,219.570000,19034363,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-06-08,220.100000,222.344900,202.500000,213.000000,213.000000,11857625,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-06-09,212.300000,221.500000,212.010000,217.440000,217.440000,8016465,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-06-10,216.620000,221.880000,207.700000,217.000000,217.000000,11763149,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-06-11,211.900000,218.900000,211.800000,218.850000,218.850000,5576026,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-06-14,213.272700,213.489900,198.000000,207.410000,207.410000,11743700,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-06-15,203.490000,207.850000,199.200000,201.590000,201.590000,6786260,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-06-16,200.000000,203.980000,193.201600,197.840000,197.840000,7215275,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-06-17,200.000000,203.922300,197.720000,202.470000,202.470000,4955160,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-06-18,201.392800,204.840000,194.510000,199.190000,199.190000,6663813,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-06-21,200.860000,211.040000,200.000000,208.240000,208.240000,7423063,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-06-22,210.760000,222.404800,210.250100,221.360000,221.360000,10066344,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-06-23,219.980000,224.570000,205.550000,212.040000,212.040000,14558440,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-06-24,214.380000,221.490000,213.460000,220.140000,220.140000,8171884,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-06-25,221.260000,226.510000,216.330000,219.940000,219.940000,13315616,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-06-28,223.000000,225.091400,215.600000,222.940000,222.940000,6190647,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-06-29,221.190000,238.400000,219.330000,234.460000,234.460000,11417039,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-06-30,237.980000,245.700000,232.410000,234.980000,234.980000,9319109,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-07-01,236.300000,236.710000,227.670000,235.110000,235.110000,5933146,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-07-02,235.100000,238.900000,230.140000,234.300000,234.300000,4200450,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-07-06,229.620000,234.600000,225.430000,233.340000,233.340000,4956460,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-07-07,231.760000,231.860000,220.820100,221.900000,221.900000,4889299,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-07-08,215.660000,233.410000,214.070000,232.790000,232.790000,8719363,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-07-09,231.965000,233.799900,224.280000,232.810000,232.810000,5305101,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-07-12,230.980000,242.389000,229.200000,239.340000,239.340000,6938180,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-07-13,239.140000,239.819500,233.801000,235.150000,235.150000,4186383,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-07-14,237.245000,249.920000,237.220000,246.660000,246.660000,9420397,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-07-15,246.660000,261.220000,245.505000,259.675000,259.675000,15130782,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-07-16,276.920000,288.880000,271.500000,286.430000,286.430000,41397251,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-07-19,284.540000,317.879600,283.140000,313.590000,313.590000,35526769,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-07-20,318.220000,342.510000,292.000000,307.330000,307.330000,123115470,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-07-21,298.510000,325.880000,293.620000,321.110000,321.110000,30859285,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-07-22,319.000000,329.600000,316.290000,323.480000,323.480000,16491283,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-07-23,330.900000,349.450000,325.170000,348.830000,348.830000,23431397,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-07-26,352.000000,362.000000,329.150000,335.870000,335.870000,23387796,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-07-27,335.308800,344.889000,318.290000,328.500000,328.500000,17196688,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-07-28,333.010000,350.990000,327.500000,349.320000,349.320000,13091567,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-07-29,350.640000,351.219900,336.000000,345.640000,345.640000,10054113,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-07-30,346.900000,359.900000,342.280000,353.600000,353.600000,11345689,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-08-02,360.000000,365.600000,343.200000,346.610000,346.610000,13685923,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-08-03,348.500400,386.980000,344.500000,386.510000,386.510000,20424075,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-08-04,385.000000,433.000000,377.110000,419.050000,419.050000,32251618,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-08-05,409.720000,443.990000,403.000000,416.260000,416.260000,25571509,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-08-06,410.300000,419.260000,393.610000,413.720000,413.720000,18924646,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-08-09,411.301400,493.756500,409.660000,484.470000,484.470000,42269876,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-08-10,485.500000,497.490000,454.000000,456.760000,456.760000,36503719,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-08-11,443.570000,453.730000,372.000000,385.330000,385.330000,53882157,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-08-12,400.000000,406.349900,377.090000,391.420000,391.420000,34345049,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-08-13,405.240000,406.320000,387.100000,389.780000,389.780000,16360347,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-08-16,379.270000,379.570000,349.000000,373.860000,373.860000,23602814,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-08-17,361.000000,402.490000,358.550100,401.860000,401.860000,25982136,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-08-18,406.500000,413.300000,386.210000,398.800000,398.800000,19121805,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-08-19,385.000000,394.919900,375.000000,375.530000,375.530000,14254720,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-08-20,374.547500,387.489900,369.260000,382.980000,382.980000,13216681,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-08-23,390.340000,411.970000,385.771600,411.890000,411.890000,15796513,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-08-24,405.690000,407.579600,387.560000,394.940000,394.940000,13957508,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-08-25,391.700000,413.800000,387.970000,397.870000,397.870000,14427609,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-08-26,395.450000,404.670000,392.152500,400.300000,400.300000,8904421,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-08-27,398.825000,398.980000,378.720000,382.220000,382.220000,13188484,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-08-30,369.000000,389.040000,362.800100,370.690000,370.690000,15529765,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-08-31,375.910000,384.680000,370.500000,376.690000,376.690000,10922476,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-09-01,382.837000,394.980000,375.200000,389.940000,389.940000,11617304,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-09-02,393.130000,402.800000,390.515000,397.660000,397.660000,8909996,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-09-03,392.710000,416.810000,388.680000,416.700000,416.700000,13859922,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-09-07,409.500000,438.550000,408.960000,436.390000,436.390000,15995088,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-09-08,433.720000,437.170000,418.200000,422.900000,422.900000,11477788,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-09-09,429.930000,459.420000,427.090000,455.920000,455.920000,22189564,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-09-10,463.156500,464.850000,448.110000,449.380000,449.380000,12604792,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-09-13,448.000000,448.809900,415.000000,419.720000,419.720000,15664748,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-09-14,419.270000,443.760000,418.633100,427.710000,427.710000,14736540,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-09-15,427.455000,437.800000,422.160000,434.460000,434.460000,12893644,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-09-16,431.210000,446.639900,429.000000,440.650000,440.650000,10107389,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-09-17,438.530000,442.000000,406.870400,430.050000,430.050000,30536393,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-09-20,417.507300,435.449900,416.511000,423.330000,423.330000,12929376,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-09-21,424.300000,439.590000,420.300000,434.040000,434.040000,9355333,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-09-22,433.090000,443.730000,428.600000,440.720000,440.720000,9003453,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-09-23,439.785100,458.500000,438.790000,454.600000,454.600000,9620341,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-09-24,448.080000,453.610000,426.610000,430.140000,430.140000,12984587,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-09-27,430.600800,434.000000,407.255000,408.840000,408.840000,13348196,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-09-28,398.560000,403.295700,376.030000,384.210000,384.210000,15935985,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-09-29,393.210000,397.980000,375.554300,378.900000,378.900000,11416664,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-09-30,381.820000,390.600000,377.100100,384.860000,384.860000,9611512,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-10-01,358.330000,359.115000,323.410000,341.090000,341.090000,34351288,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-10-04,308.880000,330.555000,305.000000,325.840000,325.840000,23331461,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-10-05,331.000000,338.032800,327.200100,332.110000,332.110000,11637491,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-10-06,318.710000,325.680000,300.620000,302.420000,302.420000,17457365,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-10-07,295.460000,317.349900,293.580000,309.360000,309.360000,15790955,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-10-08,310.800000,314.050000,297.540400,304.910000,304.910000,10631839,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-10-11,299.320000,314.110000,298.100000,305.100000,305.100000,7625781,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-10-12,313.034600,315.940000,301.910100,311.130000,311.130000,10193213,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-10-13,314.900000,327.740000,313.300000,321.500000,321.500000,12770612,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-10-14,329.000000,337.360000,322.100000,331.880000,331.880000,12851338,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-10-15,341.010000,341.549400,318.500000,324.210000,324.210000,17239834,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-10-18,322.260000,338.540000,320.537100,334.840000,334.840000,8753671,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-10-19,339.105000,347.870000,331.010100,333.610000,333.610000,8561130,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-10-20,334.010000,338.600000,329.360000,333.010000,333.010000,4983222,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-10-21,337.210000,341.520000,333.400100,339.570000,339.570000,5597599,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-10-22,332.539000,335.750000,317.180000,326.540000,326.540000,7780241,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-10-25,327.360000,350.060000,323.270000,349.560000,349.560000,9772171,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-10-26,352.000000,356.770000,341.370000,345.740000,345.740000,6673474,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-10-27,344.250000,350.640000,338.340000,340.880000,340.880000,4716018,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-10-28,343.100000,353.280000,341.540000,347.920000,347.920000,4738916,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-10-29,344.470000,347.700000,337.250100,345.210000,345.210000,4459009,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-11-01,334.990000,338.070000,320.550000,337.170000,337.170000,8605945,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-11-02,338.740000,349.450000,337.040000,348.640000,348.640000,5203610,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-11-03,350.000000,350.100000,336.200000,345.920000,345.920000,6447838,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-11-04,295.810000,297.730000,278.000000,284.020000,284.020000,30967714,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-11-05,241.570000,246.100000,210.960000,236.990000,236.990000,59630296,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-11-08,233.060000,245.920000,233.060000,244.680000,244.680000,14606791,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-11-09,246.070000,250.570000,232.210000,236.850000,236.850000,10900943,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-11-10,230.100000,239.105000,225.570000,228.960000,228.960000,9118465,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-11-11,227.670000,232.270000,221.600000,225.820000,225.820000,8359368,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-11-12,225.860000,232.559900,224.418500,231.190000,231.190000,6728877,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-11-15,230.825000,236.600000,225.630000,235.070000,235.070000,5665206,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-11-16,234.010000,239.990000,230.286100,234.280000,234.280000,5331996,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-11-17,234.790000,249.140000,234.570000,242.230000,242.230000,8015802,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-11-18,246.120000,253.190000,243.790000,251.410000,251.410000,7395597,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-11-19,265.415000,274.840000,258.090000,263.780000,263.780000,15623995,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-11-22,268.070000,289.000000,264.200000,282.690000,282.690000,13852827,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-11-23,277.740000,281.980000,269.180000,276.380000,276.380000,6903880,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-11-24,273.010000,275.279900,266.310100,273.390000,273.390000,4760232,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-11-26,319.340000,350.150000,313.000000,329.630000,329.630000,35901209,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-11-29,370.330000,376.650000,350.270000,368.510000,368.510000,33950627,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-11-30,351.580000,357.639900,337.290000,352.430000,352.430000,25159323,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-12-01,330.000000,336.359900,310.570000,310.610000,310.610000,21597146,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-12-02,301.290000,318.470000,291.030000,301.490000,301.490000,15409465,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-12-03,318.090000,318.785400,293.600000,306.720000,306.720000,12700060,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-12-06,280.850000,287.479900,256.560100,265.330000,265.330000,19844957,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-12-07,268.140000,287.770000,263.070000,282.350000,282.350000,10767102,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-12-08,282.380000,288.280000,272.910000,283.400000,283.400000,7107664,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-12-09,285.190000,285.710000,271.330000,272.210000,272.210000,5231820,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-12-10,235.405000,261.966000,233.510000,257.060000,257.060000,17506624,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-12-13,257.400000,275.780000,256.971100,271.990000,271.990000,10588651,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-12-14,264.295000,278.330000,257.200500,277.160000,277.160000,6444908,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-12-15,271.799400,290.350000,271.550000,283.280000,283.280000,9269533,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-12-16,284.200000,287.133500,277.070000,282.020000,282.020000,5974339,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-12-17,275.570000,296.390000,269.000000,294.800000,294.800000,10627523,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-12-20,321.305000,321.305000,275.120000,276.380000,276.380000,16985330,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-12-21,275.500000,281.300000,257.200000,268.140000,268.140000,12537392,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-12-22,264.060000,267.000000,245.500000,251.360000,251.360000,13957341,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-12-23,250.410000,253.650000,238.500000,249.990000,249.990000,9839176,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-12-27,243.000000,252.720000,240.580100,246.880000,246.880000,8262148,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-12-28,245.365000,254.570000,237.580000,241.440000,241.440000,9288017,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-12-29,239.330000,249.489000,233.200000,247.880000,247.880000,9144618,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-12-30,243.830000,254.320000,242.134900,251.600000,251.600000,6581803,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2021-12-31,249.880000,259.198900,246.700000,253.980000,253.980000,6751008,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-01-03,247.120000,249.420000,231.080000,235.050000,235.050000,11885913,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-01-04,232.200000,239.429900,225.240000,233.060000,233.060000,10455045,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-01-05,232.100000,237.880000,214.600000,215.230000,215.230000,9042165,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-01-06,216.035000,222.220000,205.230000,216.060000,216.060000,8173011,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-01-07,216.414000,221.966600,211.950000,213.860000,213.860000,5283143,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-01-10,211.370000,241.990000,207.500000,233.700000,233.700000,17191459,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-01-11,226.000000,228.000000,220.280100,221.390000,221.390000,7301948,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-01-12,220.480000,228.500000,218.760000,222.890000,222.890000,5846646,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-01-13,219.560000,221.499900,209.580000,210.170000,210.170000,7405741,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-01-14,204.010000,212.760000,200.080000,204.730000,204.730000,10167546,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-01-18,196.914200,198.820000,185.390000,186.610000,186.610000,10929528,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-01-19,188.840000,191.340000,173.410000,174.070000,174.070000,10398577,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-01-20,174.990000,177.470000,166.215000,167.520000,167.520000,11489632,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-01-21,166.230000,171.254300,157.290000,160.070000,160.070000,11801340,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-01-24,153.470000,158.000000,138.170000,157.300000,157.300000,16641987,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-01-25,156.010000,168.260000,150.000000,152.540000,152.540000,11474978,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-01-26,157.990000,165.850000,152.800000,154.960000,154.960000,9295899,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-01-27,157.430000,158.280000,146.540000,148.620000,148.620000,8661657,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-01-28,149.950000,159.870000,146.760000,159.470000,159.470000,6756236,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-01-31,160.050000,170.330000,154.560000,169.330000,169.330000,9292578,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-02-01,175.200000,177.570000,167.290000,172.740000,172.740000,7329761,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-02-02,170.807400,177.200000,163.580000,169.610000,169.610000,5395036,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-02-03,165.070000,170.100000,163.200000,163.950000,163.950000,4490400,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-02-04,165.640000,167.500000,160.250000,163.010000,163.010000,4375660,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-02-07,162.202700,165.540000,156.270100,160.270000,160.270000,4429256,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-02-08,155.200000,157.170000,147.570000,153.310000,153.310000,7616447,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-02-09,154.370300,164.230000,154.172500,164.030000,164.030000,5621557,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-02-10,158.000000,168.670000,157.540000,160.420000,160.420000,5965448,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-02-11,161.250000,168.790000,160.080000,161.320000,161.320000,5249692,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-02-14,157.526100,159.499900,138.140000,142.470000,142.470000,16669531,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-02-15,142.490000,152.930000,139.211000,151.120000,151.120000,10899700,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-02-16,147.620000,152.390000,144.500000,151.810000,151.810000,5536027,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-02-17,150.200000,154.660000,145.280000,146.360000,146.360000,6182300,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-02-18,147.550000,151.456100,141.310000,145.740000,145.740000,5457144,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-02-22,142.260000,151.200000,141.860000,144.970000,144.970000,6557824,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-02-23,145.170000,145.719000,134.000000,135.730000,135.730000,7822328,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-02-24,139.865000,156.420000,138.120000,156.230000,156.230000,17396035,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-02-25,156.020000,156.190000,147.010000,151.330000,151.330000,7818013,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-02-28,150.980000,155.470000,147.440000,153.600000,153.600000,6601723,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-03-01,152.480000,156.379300,147.920000,149.520000,149.520000,4842243,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-03-02,149.440000,150.570000,140.440000,147.860000,147.860000,5393578,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-03-03,147.900000,149.232000,139.530000,141.520000,141.520000,4623191,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-03-04,140.820000,143.910000,135.910000,136.460000,136.460000,5507946,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-03-07,135.120000,138.400000,126.280000,126.460000,126.460000,6177210,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-03-08,125.000000,136.960000,122.010000,129.280000,129.280000,6675723,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-03-09,132.075000,145.280000,132.050000,142.490000,142.490000,9533949,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-03-10,139.510000,140.830000,135.850000,139.520000,139.520000,5557146,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-03-11,140.750000,145.800000,138.000000,138.200000,138.200000,5356440,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-03-14,140.200000,166.750000,139.730000,150.070000,150.070000,22841078,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-03-15,156.270000,158.000000,141.750000,148.120000,148.120000,13191470,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-03-16,150.000000,169.800000,149.670000,169.360000,169.360000,14087382,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-03-17,167.750000,172.136900,160.660000,168.260000,168.260000,7786219,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-03-18,171.580000,180.800000,170.100000,178.930000,178.930000,12469605,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-03-21,179.910000,182.600000,172.440000,175.380000,175.380000,5693590,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-03-22,175.380000,188.000000,168.180000,186.720000,186.720000,8487310,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-03-23,184.660000,185.750000,176.800000,178.730000,178.730000,7317214,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-03-24,175.840000,181.860000,172.350000,179.680000,179.680000,6317254,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-03-25,178.250000,179.190000,163.031000,165.920000,165.920000,8262354,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-03-28,167.370000,174.450000,165.800000,173.080000,173.080000,6437419,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-03-29,174.070000,182.100000,171.030000,180.640000,180.640000,7226269,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-03-30,182.570000,187.709900,172.770000,174.920000,174.920000,7029003,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-03-31,175.220000,178.437100,171.110000,172.260000,172.260000,5683499,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-04-01,173.350000,179.030000,170.600000,176.590000,176.590000,4913716,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-04-04,177.240000,180.870000,171.070000,172.540000,172.540000,5915128,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-04-05,169.250000,172.395000,160.430000,162.050000,162.050000,6609422,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-04-06,157.480000,161.640000,150.705000,154.620000,154.620000,7409789,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-04-07,153.130000,159.774200,151.390000,159.000000,159.000000,5726253,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-04-08,156.790000,165.180000,156.600000,160.840000,160.840000,5456457,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-04-11,156.000000,163.350000,152.100000,160.000000,160.000000,5226721,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-04-12,158.990000,164.778400,157.000000,159.500000,159.500000,5040817,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-04-13,158.370000,172.460000,155.690000,169.660000,169.660000,6735280,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-04-14,168.590000,170.750000,164.850000,165.490000,165.490000,4348281,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-04-18,165.000000,165.889900,154.270000,154.750000,154.750000,4826017,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-04-19,151.770000,153.670000,147.230000,152.720000,152.720000,6561358,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-04-20,152.970000,153.670000,146.560100,150.120000,150.120000,3916020,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-04-21,149.430000,154.710000,144.030000,144.500000,144.500000,3911726,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-04-22,143.230000,148.810000,139.865000,140.340000,140.340000,4114099,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-04-25,139.900000,151.370000,139.400100,150.410000,150.410000,6101025,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-04-26,148.480000,151.739900,143.990000,145.790000,145.790000,5121372,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-04-27,146.090000,149.850000,139.310000,142.430000,142.430000,4716723,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-04-28,143.730000,148.450000,136.085000,142.520000,142.520000,5678914,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-04-29,144.470000,150.350000,134.190000,134.410000,134.410000,7103050,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-05-02,134.870000,146.450000,134.820000,142.080000,142.080000,7773157,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-05-03,141.930000,149.280000,137.530000,146.540000,146.540000,6326009,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-05-04,153.480000,155.460000,142.227700,155.050000,155.050000,11066027,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-05-05,151.870000,152.000000,138.650000,142.020000,142.020000,8060872,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-05-06,139.700000,140.600000,131.000000,134.400000,134.400000,7013011,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-05-09,132.790000,141.652600,131.780000,135.800000,135.800000,9625849,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-05-10,137.400000,139.055000,127.610000,132.320000,132.320000,8180204,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-05-11,130.740000,134.910000,122.720400,123.430000,123.430000,7409302,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-05-12,120.600000,132.937000,119.010000,130.170000,130.170000,7106650,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-05-13,132.310000,141.650000,132.310000,137.910000,137.910000,6494735,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-05-16,135.870000,141.600000,133.820000,136.260000,136.260000,4535615,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-05-17,137.520000,143.890000,136.090000,142.280000,142.280000,5960695,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-05-18,138.410000,144.130000,136.290000,137.710000,137.710000,4977757,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-05-19,140.870000,148.500000,140.460100,143.380000,143.380000,7708082,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-05-20,143.070000,144.770000,131.350000,136.250000,136.250000,5882504,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-05-23,137.600000,141.310000,136.235000,137.620000,137.620000,4284431,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-05-24,136.235000,136.600000,126.770000,132.060000,132.060000,6154311,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-05-25,130.980000,133.000000,126.280000,130.850000,130.850000,5343295,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-05-26,130.850000,136.140000,126.530000,135.800000,135.800000,5155570,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-05-27,137.380000,148.539900,136.590000,147.660000,147.660000,7590709,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-05-31,145.055000,149.440000,142.740000,145.330000,145.330000,8343905,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-06-01,146.090000,149.080000,140.870000,143.400000,143.400000,3646586,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-06-02,140.200000,142.500000,130.920000,140.180000,140.180000,7152203,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-06-03,139.580000,143.380000,135.070200,137.150000,137.150000,4059345,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-06-06,137.990000,143.000000,136.710000,140.000000,140.000000,3139990,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-06-07,139.370000,146.355000,137.960000,145.340000,145.340000,4072496,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-06-08,147.470000,152.730000,146.750000,148.530000,148.530000,4711257,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-06-09,148.460000,148.740000,134.000000,134.040000,134.040000,7533958,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-06-10,132.890000,134.690000,124.530000,127.120000,127.120000,6265055,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-06-13,122.710000,124.780000,115.610000,117.130000,117.130000,6700729,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-06-14,117.260000,123.150000,115.890000,121.560000,121.560000,5499054,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-06-15,122.440000,131.380000,122.440000,128.530000,128.530000,6965005,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-06-16,124.380000,125.255000,118.060000,121.080000,121.080000,5719968,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-06-17,120.730000,128.770000,120.200000,128.030000,128.030000,8355966,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-06-21,130.495000,134.575000,129.670000,129.990000,129.990000,4321370,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-06-22,127.500000,139.900000,126.590100,136.070000,136.070000,6048409,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-06-23,136.040000,143.660000,132.800000,143.260000,143.260000,4721237,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-06-24,143.990000,144.890000,138.220000,144.270000,144.270000,8480488,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-06-27,143.000000,146.400000,138.490000,145.360000,145.360000,4392762,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-06-28,143.400000,149.790000,140.950000,142.190000,142.190000,3988199,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-06-29,140.425000,144.360000,138.618000,142.810000,142.810000,2908054,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-06-30,143.400000,147.350000,135.520000,142.850000,142.850000,5631685,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-07-01,141.930000,151.100000,139.540000,149.950000,149.950000,4838179,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-07-05,148.660000,158.790000,146.840000,155.540000,155.540000,6016132,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-07-06,154.510000,161.010000,150.400000,159.560000,159.560000,4955561,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-07-07,159.500000,173.660000,159.380000,172.400000,172.400000,7626049,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-07-08,170.720000,180.730000,170.360000,176.230000,176.230000,7547201,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-07-11,173.510000,180.480000,171.290000,175.260000,175.260000,6596961,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-07-12,174.730000,176.900000,170.160000,173.250000,173.250000,5141500,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-07-13,168.880000,176.650000,167.150000,171.240000,171.240000,4075781,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-07-14,169.240000,170.861800,155.930000,159.920000,159.920000,6758967,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-07-15,161.000000,167.000000,155.930000,166.910000,166.910000,4272920,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-07-18,169.110000,172.730000,162.560000,163.400000,163.400000,3515388,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-07-19,166.760000,167.980000,161.270000,167.140000,167.140000,3006549,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-07-20,167.000000,172.510000,163.920000,166.890000,166.890000,2888851,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-07-21,165.360000,171.890000,165.250000,168.890000,168.890000,2518414,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-07-22,170.000000,171.105000,161.435000,163.520000,163.520000,2925006,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-07-25,162.750000,167.268100,159.130000,165.690000,165.690000,2488493,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-07-26,166.300000,166.300000,159.905000,160.900000,160.900000,2884682,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-07-27,161.000000,161.281900,154.100000,158.020000,158.020000,4284987,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-07-28,157.000000,158.810000,151.730000,158.070000,158.070000,3494595,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-07-29,161.440000,164.600000,159.440000,164.090000,164.090000,3858971,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-08-01,163.850000,166.179400,160.060000,161.510000,161.510000,3793993,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-08-02,161.030000,165.290000,160.760000,160.810000,160.810000,3522816,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-08-03,167.740000,189.330000,167.740000,186.490000,186.490000,13750872,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-08-04,185.750000,197.440000,185.470000,194.180000,194.180000,6876984,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-08-05,189.271000,192.400000,182.260000,186.840000,186.840000,5426044,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-08-08,185.200000,190.280000,180.090000,182.940000,182.940000,4078574,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-08-09,176.010000,180.710000,169.202100,171.140000,171.140000,5082546,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-08-10,174.090000,176.680000,169.820000,174.270000,174.270000,3550260,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-08-11,174.435000,179.850000,171.060000,171.810000,171.810000,3340457,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-08-12,172.680000,173.950000,168.640000,171.180000,171.180000,2818023,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-08-15,172.850000,179.330000,171.850000,176.780000,176.780000,4883969,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-08-16,176.000000,180.130000,166.605000,167.960000,167.960000,5053641,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-08-17,165.044500,167.620000,157.680000,158.000000,158.000000,5518239,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-08-18,157.000000,158.509900,148.260000,150.000000,150.000000,7043405,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-08-19,147.640000,150.750000,144.990000,146.100000,146.100000,4688345,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-08-22,145.250000,148.880000,141.570000,142.470000,142.470000,4488861,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-08-23,141.700000,144.808400,139.210000,143.780000,143.780000,3677613,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-08-24,142.660000,144.220000,140.630000,141.430000,141.430000,3486365,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-08-25,142.250000,142.280000,137.780000,142.050000,142.050000,3422769,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-08-26,142.800000,145.500000,136.660000,136.700000,136.700000,3997176,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-08-29,135.090000,139.370000,135.000000,137.260000,137.260000,3222096,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-08-30,137.900000,138.000000,132.818200,135.930000,135.930000,3607065,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-08-31,136.950000,139.880000,131.710000,132.270000,132.270000,4396470,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-09-01,131.130000,139.000000,130.110000,138.950000,138.950000,6664827,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-09-02,140.360000,140.930000,137.469100,138.570000,138.570000,5267679,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-09-06,138.000000,138.400000,129.820000,130.080000,130.080000,5852654,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-09-07,129.680000,135.100000,129.580000,134.900000,134.900000,3967579,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-09-08,136.700000,142.260000,136.100000,141.280000,141.280000,5053507,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-09-09,142.040000,142.650000,138.060000,142.280000,142.280000,3500908,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-09-12,142.000000,144.787800,139.760000,140.320000,140.320000,3442187,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-09-13,136.060000,138.230000,131.050000,131.300000,131.300000,4907231,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-09-14,134.010000,141.820000,133.590000,139.400000,139.400000,7904864,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-09-15,138.610000,139.839900,135.580000,135.860000,135.860000,4359813,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-09-16,134.370000,139.879900,133.760000,137.740000,137.740000,7562353,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-09-19,135.700000,135.990000,123.685400,127.900000,127.900000,11469070,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-09-20,125.800000,134.350000,125.790000,129.705000,129.705000,8551118,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-09-21,130.370000,131.790000,125.680000,125.760000,125.760000,3852922,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-09-22,124.316000,126.080000,122.900000,124.320000,124.320000,3451703,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-09-23,122.810000,125.010000,121.250000,123.640000,123.640000,3942637,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-09-26,123.340000,125.880000,119.560000,119.690000,119.690000,3824671,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-09-27,120.580000,125.160000,120.250000,122.230000,122.230000,3798010,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-09-28,123.580000,126.290000,121.820000,122.150000,122.150000,4245868,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-09-29,119.900000,120.580000,115.030000,118.070000,118.070000,4757236,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-09-30,118.440000,122.580000,118.080000,118.250000,118.250000,3856002,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-10-03,119.320000,122.398100,115.410000,120.990000,120.990000,3812179,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-10-04,123.670000,126.410000,123.500000,125.670000,125.670000,3464287,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-10-05,122.400000,126.740000,121.610000,125.620000,125.620000,2277578,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-10-06,124.780000,127.640000,122.930000,125.150000,125.150000,2363404,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-10-07,121.500000,123.360000,118.460000,119.320000,119.320000,3158392,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-10-10,119.320000,125.250000,118.470000,123.420000,123.420000,3824119,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-10-11,123.290000,124.780000,118.940000,120.720000,120.720000,2963700,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-10-12,135.555000,141.470000,129.610000,130.720000,130.720000,17675978,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-10-13,126.360000,136.119900,126.190000,134.720000,134.720000,5068095,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-10-14,135.680000,136.160000,131.314800,134.000000,134.000000,4581428,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-10-17,135.520000,140.320000,133.000000,139.250000,139.250000,4638378,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-10-18,140.740000,141.000000,132.390000,134.090000,134.090000,5096228,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-10-19,132.500000,133.290000,122.920000,123.520000,123.520000,6024473,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-10-20,122.940000,124.690000,118.310000,118.380000,118.380000,5497710,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-10-21,123.770000,130.300000,122.030000,128.320000,128.320000,8129290,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-10-24,127.490000,133.960000,126.720000,133.020000,133.020000,4102743,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-10-25,134.000000,138.350000,133.000600,136.570000,136.570000,4345339,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-10-26,137.250000,147.680000,137.020000,142.000000,142.000000,5736947,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-10-27,143.380000,146.250000,140.800000,144.110000,144.110000,3672444,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-10-28,142.840000,151.190000,142.840000,150.970000,150.970000,4567878,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-10-31,149.430000,154.340000,148.570000,150.330000,150.330000,3675236,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-11-01,154.770000,158.880000,152.410000,154.620000,154.620000,4344258,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-11-02,154.200000,156.180000,148.300000,148.620000,148.620000,5048359,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-11-03,138.760000,150.746400,135.090000,147.500000,147.500000,9194401,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-11-04,149.620000,160.740000,143.645000,158.410000,158.410000,8108538,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-11-07,158.460000,165.490000,155.810000,164.040000,164.040000,4858549,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-11-08,162.460000,167.490000,159.060000,164.610000,164.610000,3389219,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-11-09,162.500000,169.830000,162.350000,163.210000,163.210000,3813822,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-11-10,164.525000,169.280000,161.710000,168.560000,168.560000,4886057,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-11-11,168.310000,172.135000,162.740000,171.200000,171.200000,3611647,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-11-14,169.270000,184.240000,169.270000,179.030000,179.030000,6662503,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-11-15,180.660000,187.870000,178.350000,185.470000,185.470000,5159030,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-11-16,184.440000,188.650000,182.880000,185.250000,185.250000,4029981,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-11-17,181.330000,184.440000,178.980000,183.900000,183.900000,3372363,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-11-18,184.000000,188.450000,181.220000,181.590000,181.590000,3549453,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-11-21,179.710000,180.790000,175.170000,176.750000,176.750000,3100124,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-11-22,176.080000,179.830000,170.270000,179.590000,179.590000,3307117,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-11-23,178.010000,179.360000,174.580000,176.810000,176.810000,2311841,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-11-25,175.010000,179.140000,173.410000,176.400000,176.400000,1221141,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-11-28,177.090000,184.220000,174.670000,175.380000,175.380000,3749423,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-11-29,176.150000,179.000000,171.530000,173.150000,173.150000,2840909,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-11-30,173.520000,176.750000,169.060000,175.910000,175.910000,3720186,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-12-01,173.410000,185.900000,172.380000,181.480000,181.480000,4871969,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-12-02,178.500000,182.800000,177.000000,182.350000,182.350000,2765421,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-12-05,180.990000,183.685000,173.590000,175.930000,175.930000,3525387,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-12-06,175.020000,175.780000,169.700000,173.540000,173.540000,3392302,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-12-07,172.310000,180.385000,171.850000,179.000000,179.000000,3579317,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-12-08,179.120000,185.210000,177.520000,184.700000,184.700000,3414039,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-12-09,185.000000,185.409000,177.100000,177.350000,177.350000,3497758,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-12-12,175.530000,175.772500,162.780000,165.130000,165.130000,5202241,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-12-13,187.330000,208.520000,184.020000,197.540000,197.540000,26239598,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-12-14,195.080000,217.250000,192.541000,208.950000,208.950000,21435190,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-12-15,207.610000,212.440000,202.090000,207.250000,207.250000,9646692,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-12-16,206.370000,209.850000,190.620000,193.290000,193.290000,11819352,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-12-19,200.000000,204.000000,187.860100,189.890000,189.890000,6953325,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-12-20,189.000000,204.220000,187.540000,201.160000,201.160000,9561803,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-12-21,201.850000,210.220000,199.750000,210.040000,210.040000,7584039,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-12-22,209.820000,212.470000,201.610100,208.340000,208.340000,5376622,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-12-23,206.690000,208.990000,197.560000,199.080000,199.080000,6166010,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-12-27,199.900000,201.430000,179.830000,180.170000,180.170000,6735964,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-12-28,180.000000,183.750000,174.510000,176.500000,176.500000,5525574,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-12-29,178.190000,182.500000,175.400100,178.860000,178.860000,3746780,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
2022-12-30,176.220000,179.690000,172.310000,179.620000,179.620000,3435953,0.000000,1.000000,MRNA,Common Stock,Moderna Inc,"Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.",1682852,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US",https://www.modernatx.com,December,2025-03-31,11791764000,-3536999936,None,0,26.01,None,None,-8.73,8.25,-1.057,-9.72,-0.158,-0.293,3177000000,-2616999936,-8.73,-0.851,-0.353,47.59,1,5,17,1,3,-,32.47,3.712,1.171,2.09,4.641,1.859,129.39,23.15,26.7,38.22,386742000,360977000,7.279,73.671,None,None
